Related Experiment Video

Updated: Mar 6, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via

Pu Li1, Chenkui Miao1, Chao Liang1

  • 1State Key Laboratory of Reproductive Medicine and Department of Urology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.

Biomed Research International
|March 11, 2017
PubMed

Insights

Calpain 2 (CAPN2) is upregulated in castration-resistant prostate cancer (CRPC), inhibiting cell proliferation and metastasis. Targeting CAPN2 offers a potential therapeutic strategy for CRPC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Castration-resistant prostate cancer (CRPC) is an advanced stage of prostate cancer with limited treatment options.
  • Understanding the molecular mechanisms driving CRPC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of Calpain 2 (CAPN2) in the development and progression of castration-resistant prostate cancer.
  • To explore CAPN2 as a potential therapeutic target for CRPC.

Main Methods:

  • Quantitative real-time PCR to assess CAPN2 mRNA expression in CRPC cell lines (DU145, PC3) and prostate cancer tissues.
  • Gene silencing techniques (e.g., siRNA) to inhibit CAPN2 expression in CRPC cells.
  • Cell proliferation assays (e.g., cell cycle analysis).
  • Cell migration and invasion assays.
  • Western blotting to analyze the activation of downstream signaling pathways (MMP-2, MMP-9, AKT, mTOR).

Main Results:

  • CAPN2 mRNA expression was significantly upregulated in CRPC cells (DU145, PC3) compared to non-CRPC cells.
  • Silencing CAPN2 inhibited CRPC cell proliferation by inducing cell cycle arrest at the G1 phase.
  • Knockdown of CAPN2 suppressed CRPC cell migration and invasion by reducing matrix metalloproteinase-2 (MMP-2) and MMP-9 activation.
  • CAPN2 inhibition repressed the phosphorylation of AKT and mTOR signaling pathways.
  • Elevated CAPN2 expression was observed in prostate cancer tissues compared to normal controls.

Conclusions:

  • CAPN2 plays a critical role in the proliferation, migration, and invasion of castration-resistant prostate cancer cells.
  • The findings suggest that CAPN2 is a promising therapeutic target for treating castration-resistant prostate cancer.
  • Targeting CAPN2 may offer a novel strategy to overcome therapeutic resistance in advanced prostate cancer.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.6K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K